The Carlat Psychiatry Podcast

This discussion highlights the crucial role of timing in diagnosing bipolar disorder. It examines the historical challenges in diagnosis and the effectiveness of screening tools like the Mood Disorder Questionnaire. Attention is given to the critical window for recognizing symptoms early, emphasizing the risk of misdiagnosis. The Bipolarity Index is introduced as a valuable assessment tool, alongside the Rapid Mood Screener, showcasing their potential to improve diagnostic precision and outcomes for patients.

Learn how your patient’s life story can unlock psychotherapeutic avenues of treatment on our interview with Margaret Chisolm.CME: Take the CME Post-Test for this EpisodePublished On: 02/03/2025Duration: 16 minutes, 41 secondsChris Aiken, MD, Margaret Chisolm, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Learn how an understanding of patient’s temperament and the meaning of their life story can unlock psychotherapeutic avenues of treatment on our interview with Margaret Chisolm.CME: Take the CME Post-Test for this EpisodePublished On: 01/27/2025Duration: 18 minutes, 12 secondsChris Aiken, MD, Margaret Chisolm, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Margaret Chisolm shares the Perspectives model, a way of assessing patients that builds on the DSM takes the famous manual a few steps further.CME: Take the CME Post-Test for this EpisodePublished On: 01/20/2025Duration: 22 minutes, 23 secondsChris Aiken, MD, Margaret Chisolm, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Depression and cognitive impairment on benzos, tardive dyskinesia, anticholinergics, and neurotoxicity from high dose stimulants. These are the side effects that patients aren’t likely to notice until it’s too late.CME: Take the CME Post-Test for this EpisodePublished On: 01/13/2025Duration: 07 minutes, 41 secondsChris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Allen Frances shares his approach to chronic depression.CME: Take the CME Post-Test for this EpisodePublished On: 01/06/2025Duration: 16 minutes, 47 secondsChris Aiken, Allen Frances, MD, and Kellie Newsome, PMHNP, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Allen Frances shares his approach to chronic depression.CME: Take the CME Post-Test for this EpisodePublished On: 12/30/2024Duration: 16 minutes, 45 secondsChris Aiken, MD, Allen Frances, MD, and Kellie Newsome, PMHNP, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Allen Frances shows us how to put the common ingredients of effective therapy into practice at every visit.CME: Take the CME Post-Test for this EpisodePublished On: 12/23/2024Duration: 16 minutes, 53 secondsChris Aiken, Allen Frances, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Allen Frances shows us how to adjust our therapeutic approach for problems that are simple and those a bit more complex.CME: Take the CME Post-Test for this EpisodePublished On: 12/16/2024Duration: 21 minutes, 45 secondsChris Aiken, Allen Frances, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We talk with Nick Rosenlicht, MD about what’s gone wrong in the mental health care system.CME: Take the CME Post-Test for this EpisodePublished On: 12/09/2024Duration: 23 minutes, 57 secondsChris Aiken, Nicholas Rosenlicht, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.